Matulonis UA, Lorusso D, Oaknin A, Pignata S, et al. Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. J Clin Oncol 2023 Jan 30:JCO2201900. doi: 10.1200/JCO.22.01900.
PMID: 36716407